Literature DB >> 23810009

Role of KLF5 in hormonal signaling and breast cancer development.

Rong Liu1, Jin-Tang Dong, Ceshi Chen.   

Abstract

Steroid hormones, including ovarian steroid hormones progesterone and estrogen and androgen, play vital roles in the development of normal mammary gland and breast cancer via their receptors. How these hormones regulate these physiological and pathological processes remains to be elucidated. Krüppel-like factor 5 (KLF5) is a transcription factor playing significant roles in breast carcinogenesis, whose expression has been shown to be regulated by hormones. In this review, the relationships among hormonal signaling, KLF5, and breast cancer are summarized and discussed.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23810009     DOI: 10.1016/B978-0-12-416673-8.00002-2

Source DB:  PubMed          Journal:  Vitam Horm        ISSN: 0083-6729            Impact factor:   3.421


  4 in total

1.  MicroRNA-153 inhibits the proliferation and invasion of human laryngeal squamous cell carcinoma by targeting KLF5.

Authors:  Jian-Yong Liu; Jian-Bin Lu; Yue Xu
Journal:  Exp Ther Med       Date:  2016-03-24       Impact factor: 2.447

Review 2.  Prognostic role of hormone receptors in endometrial cancer: a systematic review and meta-analysis.

Authors:  Yanli Zhang; Dong Zhao; Changguo Gong; Fengmei Zhang; Jing He; Wei Zhang; Yulan Zhao; Jing Sun
Journal:  World J Surg Oncol       Date:  2015-06-25       Impact factor: 2.754

3.  Treatment with a brain-selective prodrug of 17β-estradiol improves cognitive function in Alzheimer's disease mice by regulating klf5-NF-κB pathway.

Authors:  Wenhao Yan; Jun Wu; Bo Song; Qiang Luo; Yuming Xu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-03-16       Impact factor: 3.000

4.  miR-217 inhibits triple-negative breast cancer cell growth, migration, and invasion through targeting KLF5.

Authors:  Wenhui Zhou; Fangfang Song; Qiuju Wu; Rong Liu; Lulu Wang; Cuicui Liu; You Peng; Shuqin Mao; Jing Feng; Ceshi Chen
Journal:  PLoS One       Date:  2017-04-24       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.